KRAS and neoplasm: Of note, among the downregulated pathways are comprised KRAS, Hypoxia, and Epithelial Mesenchymal Transition (Figure 1C and Supplementary Figure S1), all related to the tumorigenic process, providing further support to the overall effect of impairing cell proliferation and tumor growth [32,33,34].